APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dry Powder Inhaler Device

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

Selected research

Market Outlook & Growth Opportunities

Global Dry Powder Inhaler Device Market Outlook and Growth Opportunities 2026

1 January 2026192 pages

Choose your research edition.

Industry ResearchDry Powder Inhaler Device Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Powder Inhaler Device Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Dry Powder Inhaler Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Powder Inhaler Device Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Powder Inhaler Device Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.

From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.

Read the full market overview

Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.

According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

This report provides an overview of the global Dry Powder Inhaler Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dry Powder Inhaler Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dry Powder Inhaler Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dry Powder Inhaler Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Dry Powder Inhaler Device Segment by Company

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Chiesi

Cipla

3M

Hovione

Mannkind

Mylan

Novartis

Schering/Merck

Teva

Vectura

Dry Powder Inhaler Device Segment by Type

Single Dose

Multi Dose

Dry Powder Inhaler Device Segment by Application

Asthma

COPD

Others

Dry Powder Inhaler Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dry Powder Inhaler Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dry Powder Inhaler Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dry Powder Inhaler Device significant trends, drivers, influence factors in global and regions.

6. To analyze Dry Powder Inhaler Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Inhaler Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Inhaler Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Inhaler Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dry Powder Inhaler Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dry Powder Inhaler Device industry.

Chapter 3: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dry Powder Inhaler Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dry Powder Inhaler Device Industry Trends Table 2. Dry Powder Inhaler Device Industry Drivers Table 3. Dry Powder Inhaler Device Industry Opportunities and Challenges Table 4. Dry Powder Inhaler Device Industry Restraints Table 5. Global Dry Powder Inhaler Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dry Powder Inhaler Device Revenue Share by Company (2021-2026) Table 7. Global Dry Powder Inhaler Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Dry Powder Inhaler Device Sales Volume Share by Company (2021-2026) Table 9. Global Dry Powder Inhaler Device Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Dry Powder Inhaler Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dry Powder Inhaler Device Key Company Manufacturing Base & Headquarters Table 12. Global Dry Powder Inhaler Device Company, Product Type & Application Table 13. Global Dry Powder Inhaler Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dry Powder Inhaler Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Dose Table 18. Significant Companies of Multi Dose Table 19. Global Dry Powder Inhaler Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Dry Powder Inhaler Device Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Dry Powder Inhaler Device Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Dry Powder Inhaler Device Sales Volume Share by Type (2021-2026) Table 23. Global Dry Powder Inhaler Device Sales Volume Share by Type (2027-2032) Table 24. Global Dry Powder Inhaler Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dry Powder Inhaler Device Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Dry Powder Inhaler Device Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Dry Powder Inhaler Device Sales Value Share by Type (2021-2026) Table 28. Global Dry Powder Inhaler Device Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Asthma Table 30. Significant Companies of COPD Table 31. Significant Companies of Others Table 32. Global Dry Powder Inhaler Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Dry Powder Inhaler Device Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Dry Powder Inhaler Device Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Dry Powder Inhaler Device Sales Volume Share by Application (2021-2026) Table 36. Global Dry Powder Inhaler Device Sales Volume Share by Application (2027-2032) Table 37. Global Dry Powder Inhaler Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Dry Powder Inhaler Device Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Dry Powder Inhaler Device Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Dry Powder Inhaler Device Sales Value Share by Application (2021-2026) Table 41. Global Dry Powder Inhaler Device Sales Value Share by Application (2027-2032) Table 42. Global Dry Powder Inhaler Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Dry Powder Inhaler Device Sales by Region (2021-2026) & (K Units) Table 44. Global Dry Powder Inhaler Device Sales Market Share by Region (2021-2026) Table 45. Global Dry Powder Inhaler Device Sales by Region (2027-2032) & (K Units) Table 46. Global Dry Powder Inhaler Device Sales Market Share by Region (2027-2032) Table 47. Global Dry Powder Inhaler Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dry Powder Inhaler Device Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Dry Powder Inhaler Device Sales Value Share by Region (2021-2026) Table 50. Global Dry Powder Inhaler Device Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Dry Powder Inhaler Device Sales Value Share by Region (2027-2032) Table 52. Global Dry Powder Inhaler Device Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Dry Powder Inhaler Device Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Dry Powder Inhaler Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Dry Powder Inhaler Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 57. Global Dry Powder Inhaler Device Sales Market Share by Country (2021-2026) Table 58. Global Dry Powder Inhaler Device Sales by Country (2027-2032) & (K Units) Table 59. Global Dry Powder Inhaler Device Sales Market Share by Country (2027-2032) Table 60. Global Dry Powder Inhaler Device Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Dry Powder Inhaler Device Sales Value Market Share by Country (2021-2026) Table 62. Global Dry Powder Inhaler Device Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Dry Powder Inhaler Device Sales Value Market Share by Country (2027-2032) Table 64. GlaxoSmithKline Company Information Table 65. GlaxoSmithKline Business Overview Table 66. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio Table 68. GlaxoSmithKline Recent Development Table 69. AstraZeneca Company Information Table 70. AstraZeneca Business Overview Table 71. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. AstraZeneca Dry Powder Inhaler Device Product Portfolio Table 73. AstraZeneca Recent Development Table 74. Boehringer Ingelheim Company Information Table 75. Boehringer Ingelheim Business Overview Table 76. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio Table 78. Boehringer Ingelheim Recent Development Table 79. Chiesi Company Information Table 80. Chiesi Business Overview Table 81. Chiesi Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Chiesi Dry Powder Inhaler Device Product Portfolio Table 83. Chiesi Recent Development Table 84. Cipla Company Information Table 85. Cipla Business Overview Table 86. Cipla Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Cipla Dry Powder Inhaler Device Product Portfolio Table 88. Cipla Recent Development Table 89. 3M Company Information Table 90. 3M Business Overview Table 91. 3M Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. 3M Dry Powder Inhaler Device Product Portfolio Table 93. 3M Recent Development Table 94. Hovione Company Information Table 95. Hovione Business Overview Table 96. Hovione Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Hovione Dry Powder Inhaler Device Product Portfolio Table 98. Hovione Recent Development Table 99. Mannkind Company Information Table 100. Mannkind Business Overview Table 101. Mannkind Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Mannkind Dry Powder Inhaler Device Product Portfolio Table 103. Mannkind Recent Development Table 104. Mylan Company Information Table 105. Mylan Business Overview Table 106. Mylan Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Mylan Dry Powder Inhaler Device Product Portfolio Table 108. Mylan Recent Development Table 109. Novartis Company Information Table 110. Novartis Business Overview Table 111. Novartis Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Novartis Dry Powder Inhaler Device Product Portfolio Table 113. Novartis Recent Development Table 114. Schering/Merck Company Information Table 115. Schering/Merck Business Overview Table 116. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Schering/Merck Dry Powder Inhaler Device Product Portfolio Table 118. Schering/Merck Recent Development Table 119. Teva Company Information Table 120. Teva Business Overview Table 121. Teva Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. Teva Dry Powder Inhaler Device Product Portfolio Table 123. Teva Recent Development Table 124. Vectura Company Information Table 125. Vectura Business Overview Table 126. Vectura Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. Vectura Dry Powder Inhaler Device Product Portfolio Table 128. Vectura Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Dry Powder Inhaler Device Distributors List Table 132. Dry Powder Inhaler Device Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Dry Powder Inhaler Device Product Image Figure 2. Global Dry Powder Inhaler Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dry Powder Inhaler Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dry Powder Inhaler Device Sales (2021-2032) & (K Units) Figure 5. Global Dry Powder Inhaler Device Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Dry Powder Inhaler Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Dose Image Figure 10. Multi Dose Image Figure 11. Global Dry Powder Inhaler Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Dry Powder Inhaler Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Dry Powder Inhaler Device Sales Volume Share by Type (2021-2032) Figure 14. Global Dry Powder Inhaler Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Dry Powder Inhaler Device Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Dry Powder Inhaler Device Sales Value Share by Type (2021-2032) Figure 17. Asthma Image Figure 18. COPD Image Figure 19. Others Image Figure 20. Global Dry Powder Inhaler Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Dry Powder Inhaler Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Dry Powder Inhaler Device Sales Volume Share by Application (2021-2032) Figure 23. Global Dry Powder Inhaler Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Dry Powder Inhaler Device Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Dry Powder Inhaler Device Sales Value Share by Application (2021-2032) Figure 26. Global Dry Powder Inhaler Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Dry Powder Inhaler Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Dry Powder Inhaler Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Dry Powder Inhaler Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Dry Powder Inhaler Device Sales Value (2021-2032) & (US$ Million) Figure 31. North America Dry Powder Inhaler Device Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Dry Powder Inhaler Device Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Dry Powder Inhaler Device Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Dry Powder Inhaler Device Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Dry Powder Inhaler Device Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Dry Powder Inhaler Device Sales Value (2021-2032) & (US$ Million) Figure 37. South America Dry Powder Inhaler Device Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Dry Powder Inhaler Device Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Dry Powder Inhaler Device Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Dry Powder Inhaler Device Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Dry Powder Inhaler Device Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose
  • Multi Dose
Applications
  • Asthma
  • COPD
  • Others
Companies covered
  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim
  • Chiesi
  • Cipla
  • 3M
  • Hovione
  • Mannkind
  • Mylan
  • Novartis
  • Schering/Merck
  • Teva
  • Vectura

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dry Powder Inhaler Device Sales Value (2021-2032)
  4. 1.2.2 Global Dry Powder Inhaler Device Sales Volume (2021-2032)
  5. 1.2.3 Global Dry Powder Inhaler Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dry Powder Inhaler Device Market Dynamics
  1. 2.1 Dry Powder Inhaler Device Industry Trends
  2. 2.2 Dry Powder Inhaler Device Industry Drivers
  3. 2.3 Dry Powder Inhaler Device Industry Opportunities and Challenges
  4. 2.4 Dry Powder Inhaler Device Industry Restraints
3 Dry Powder Inhaler Device Market by Company
  1. 3.1 Global Dry Powder Inhaler Device Company Revenue Ranking in 2025
  2. 3.2 Global Dry Powder Inhaler Device Revenue by Company (2021-2026)
  3. 3.3 Global Dry Powder Inhaler Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Dry Powder Inhaler Device Average Price by Company (2021-2026)
  5. 3.5 Global Dry Powder Inhaler Device Company Ranking (2024-2026)
  6. 3.6 Global Dry Powder Inhaler Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Dry Powder Inhaler Device Company Product Type and Application
  8. 3.8 Global Dry Powder Inhaler Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dry Powder Inhaler Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dry Powder Inhaler Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dry Powder Inhaler Device Market by Type
  1. 4.1 Dry Powder Inhaler Device Type Introduction
  2. 4.1.1 Single Dose
  3. 4.1.2 Multi Dose
  4. 4.2 Global Dry Powder Inhaler Device Sales Volume by Type
  5. 4.2.1 Global Dry Powder Inhaler Device Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dry Powder Inhaler Device Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Dry Powder Inhaler Device Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Dry Powder Inhaler Device Sales Value by Type
  9. 4.3.1 Global Dry Powder Inhaler Device Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dry Powder Inhaler Device Sales Value by Type (2021-2032)
  11. 4.3.3 Global Dry Powder Inhaler Device Sales Value Share by Type (2021-2032)
5 Dry Powder Inhaler Device Market by Application
  1. 5.1 Dry Powder Inhaler Device Application Introduction
  2. 5.1.1 Asthma
  3. 5.1.2 COPD
  4. 5.1.3 Others
  5. 5.2 Global Dry Powder Inhaler Device Sales Volume by Application
  6. 5.2.1 Global Dry Powder Inhaler Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dry Powder Inhaler Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dry Powder Inhaler Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dry Powder Inhaler Device Sales Value by Application
  10. 5.3.1 Global Dry Powder Inhaler Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dry Powder Inhaler Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dry Powder Inhaler Device Sales Value Share by Application (2021-2032)
6 Dry Powder Inhaler Device Regional Sales and Value Analysis
  1. 6.1 Global Dry Powder Inhaler Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dry Powder Inhaler Device Sales by Region (2021-2032)
  3. 6.2.1 Global Dry Powder Inhaler Device Sales by Region: 2021-2026
  4. 6.2.2 Global Dry Powder Inhaler Device Sales by Region (2027-2032)
  5. 6.3 Global Dry Powder Inhaler Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dry Powder Inhaler Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dry Powder Inhaler Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dry Powder Inhaler Device Sales Value by Region (2027-2032)
  9. 6.5 Global Dry Powder Inhaler Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dry Powder Inhaler Device Sales Value (2021-2032)
  12. 6.6.2 North America Dry Powder Inhaler Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dry Powder Inhaler Device Sales Value (2021-2032)
  15. 6.7.2 Europe Dry Powder Inhaler Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dry Powder Inhaler Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dry Powder Inhaler Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dry Powder Inhaler Device Sales Value (2021-2032)
  21. 6.9.2 South America Dry Powder Inhaler Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dry Powder Inhaler Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dry Powder Inhaler Device Sales Value Share by Country, 2025 VS 2032
7 Dry Powder Inhaler Device Country-level Sales and Value Analysis
  1. 7.1 Global Dry Powder Inhaler Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dry Powder Inhaler Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dry Powder Inhaler Device Sales by Country (2021-2032)
  4. 7.3.1 Global Dry Powder Inhaler Device Sales by Country (2021-2026)
  5. 7.3.2 Global Dry Powder Inhaler Device Sales by Country (2027-2032)
  6. 7.4 Global Dry Powder Inhaler Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dry Powder Inhaler Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dry Powder Inhaler Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dry Powder Inhaler Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dry Powder Inhaler Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dry Powder Inhaler Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline
  2. 8.1.1 GlaxoSmithKline Company Information
  3. 8.1.2 GlaxoSmithKline Business Overview
  4. 8.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
  6. 8.1.5 GlaxoSmithKline Recent Developments
  7. 8.2 AstraZeneca
  8. 8.2.1 AstraZeneca Company Information
  9. 8.2.2 AstraZeneca Business Overview
  10. 8.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
  12. 8.2.5 AstraZeneca Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Chiesi
  20. 8.4.1 Chiesi Company Information
  21. 8.4.2 Chiesi Business Overview
  22. 8.4.3 Chiesi Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
  24. 8.4.5 Chiesi Recent Developments
  25. 8.5 Cipla
  26. 8.5.1 Cipla Company Information
  27. 8.5.2 Cipla Business Overview
  28. 8.5.3 Cipla Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
  30. 8.5.5 Cipla Recent Developments
  31. 8.6 3M
  32. 8.6.1 3M Company Information
  33. 8.6.2 3M Business Overview
  34. 8.6.3 3M Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 3M Dry Powder Inhaler Device Product Portfolio
  36. 8.6.5 3M Recent Developments
  37. 8.7 Hovione
  38. 8.7.1 Hovione Company Information
  39. 8.7.2 Hovione Business Overview
  40. 8.7.3 Hovione Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
  42. 8.7.5 Hovione Recent Developments
  43. 8.8 Mannkind
  44. 8.8.1 Mannkind Company Information
  45. 8.8.2 Mannkind Business Overview
  46. 8.8.3 Mannkind Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
  48. 8.8.5 Mannkind Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
  60. 8.10.5 Novartis Recent Developments
  61. 8.11 Schering/Merck
  62. 8.11.1 Schering/Merck Company Information
  63. 8.11.2 Schering/Merck Business Overview
  64. 8.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
  66. 8.11.5 Schering/Merck Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Teva Dry Powder Inhaler Device Product Portfolio
  72. 8.12.5 Teva Recent Developments
  73. 8.13 Vectura
  74. 8.13.1 Vectura Company Information
  75. 8.13.2 Vectura Business Overview
  76. 8.13.3 Vectura Dry Powder Inhaler Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
  78. 8.13.5 Vectura Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dry Powder Inhaler Device Value Chain Analysis
  2. 9.1.1 Dry Powder Inhaler Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dry Powder Inhaler Device Sales Mode & Process
  6. 9.2 Dry Powder Inhaler Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dry Powder Inhaler Device Distributors
  9. 9.2.3 Dry Powder Inhaler Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst